Zevra Therapeutics Inc (ZVRA): Next-Year EPS Estimate 32.38%
As of 2026-06-08, Zevra Therapeutics Inc (ZVRA) has a next-year EPS growth estimate of 32.38%.
On 2026-06-08, analyst consensus for ZVRA's next-year EPS growth shifted from 38.66% to 32.38% — a negative change of 6.28 percentage points. Current-year growth is projected at -25.27%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 32.38%
- EPS growth this year
- -25.27%
- EPS next quarter (est)
- $0.11
- Last price
- $12.09
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-08 | 32.38% | -25.27% | $0.11 | $12.09 |
| 2026-06-07 | 38.66% | -25.27% | $0.11 | $10.61 |
| 2026-06-04 | 38.66% | -25.27% | $0.11 | $11.17 |
| 2026-06-03 | 38.66% | -25.27% | $0.11 | $10.96 |
| 2026-06-02 | 38.66% | -25.27% | $0.11 | $10.88 |
| 2026-06-01 | 38.66% | -25.27% | $0.11 | $11.49 |
| 2026-05-31 | 38.66% | -25.27% | $0.11 | $11.59 |
| 2026-05-28 | 38.66% | -25.27% | $0.11 | $11.40 |
| 2026-05-27 | 38.66% | -25.27% | $0.11 | $10.95 |
| 2026-05-26 | 38.66% | -25.27% | $0.11 | $10.32 |
| 2026-05-25 | 38.66% | -25.27% | $0.11 | $10.03 |
| 2026-05-24 | 38.66% | -25.27% | $0.11 | $10.03 |
| 2026-05-21 | 38.66% | -25.27% | $0.11 | $10.49 |
| 2026-05-20 | 38.66% | -25.27% | $0.11 | $10.24 |
| 2026-05-19 | 38.66% | -25.27% | $0.11 | $10.20 |
| 2026-05-18 | 38.66% | -25.27% | $0.11 | $10.43 |
| 2026-05-17 | 38.66% | -25.27% | $0.11 | $11.01 |
| 2026-05-14 | 38.66% | -25.27% | $0.11 | $11.66 |
| 2026-05-13 | 38.66% | -25.27% | $0.11 | $11.20 |
| 2026-05-12 | 38.66% | -25.27% | $0.11 | $11.05 |
| 2026-05-11 | 38.66% | -25.27% | $0.11 | $10.80 |
| 2026-05-10 | 38.66% | -25.27% | $0.11 | $11.13 |
| 2026-05-07 | 55.19% | -32.63% | $0.09 | $11.00 |
| 2026-05-06 | 205.48% | -63.95% | $0.08 | $11.25 |
| 2026-05-05 | 205.48% | -63.95% | $0.08 | $10.61 |
| 2026-05-04 | 205.48% | -63.95% | $0.08 | $10.05 |
| 2026-05-03 | 205.48% | -63.95% | $0.08 | $10.07 |
| 2026-04-30 | 205.48% | -63.95% | $0.08 | $10.17 |
| 2026-04-29 | 205.48% | -63.95% | $0.08 | $9.67 |
| 2026-04-28 | 205.48% | -63.95% | $0.08 | $9.90 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Zevra Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-08, Zevra Therapeutics Inc (ZVRA) has a next-year EPS growth estimate of 32.38%, based on analyst consensus.
When was the latest EPS estimate revision for ZVRA?▾
The most recent revision occurred on 2026-06-08, when analysts adjusted the next-year EPS growth estimate from 38.66% to 32.38%.
What sector and industry does Zevra Therapeutics Inc belong to?▾
Zevra Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ZVRA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Zevra Therapeutics Inc (ZVRA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports